TipRanks
Go Ultimate55% OFF

Oaktree Acquisition Corp. III Life Sciences Class A (OACC) Financial Statements

Oaktree Acquisition Corp. III Life Sciences Class A Financial Overview

Oaktree Acquisition Corp. III Life Sciences Class A's market cap is currently $263.53M. The company's EPS TTM is $0.28; its P/E ratio is 37.91; Oaktree Acquisition Corp. III Life Sciences Class A has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24
Income Statement
Total Revenue$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00
Operating Income$ -1.20M$ -703.00
EBITDA$ -1.20M$ 702.91K
Net Income$ 7.29M$ 2.66K
Balance Sheet
Cash & Short-Term Investments$ 1.43M$ 1.36M
Total Assets$ 203.11M$ 195.25M
Total Debt$ 11.82K$ 11.82K
Net Debt$ -1.42M$ -1.35M
Total Liabilities$ 8.32M$ 7.75M
Stockholders' Equity$ 194.79M$ 187.50M
Cash Flow
Free Cash Flow$ -422.08K$ -179.00
Operating Cash Flow$ -422.08K$ -89.69K
Investing Cash Flow$ 500.00K$ -191.99M
Financing Cash Flow$ 0.00$ 193.44M

Currency in USD

Oaktree Acquisition Corp. III Life Sciences Class A Earnings and Revenue History

03M6M9M0 %0.4 %0.8 %1.2 %EarningsProfit Margin20242025RevenueEarningsProfit Margin

Oaktree Acquisition Corp. III Life Sciences Class A Debt to Assets

080M160M240M3.96 %4.02 %4.08 %4.14 %LiabilitiesDebt to Assets20242025AssetsLiabilitiesDebt to Assets

Oaktree Acquisition Corp. III Life Sciences Class A Cash Flow

-300M-200M-100M0100M200M300M20242025OperatingInvestingFinancing

Oaktree Acquisition Corp. III Life Sciences Class A Forecast EPS vs Actual EPS